Mutations in NDUFB11, encoding a complex i component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome

Vanessa A. Van Rahden, Erika Fernandez-Vizarra, Malik Alawi, Kristina Brand, Florence Fellmann, Denise Horn, Massimo Zeviani, Kerstin Kutsche

Research output: Contribution to journalArticle

Abstract

Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject's mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH:ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.

Original languageEnglish
Pages (from-to)640-650
Number of pages11
JournalAmerican Journal of Human Genetics
Volume96
Issue number4
DOIs
Publication statusPublished - Apr 2 2015

Fingerprint

Electron Transport
Mutation
Aborted Fetus
Exome
Electron Transport Complex I
X Chromosome Inactivation
Mitochondrial Diseases
X-Linked Genes
Nonsense Codon
Electron Transport Complex III
X Chromosome
HeLa Cells
Small Interfering RNA
Cell Survival
Phenotype
Enzymes
Growth
Syndromic 7 Microphthalmia
Proteins

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Mutations in NDUFB11, encoding a complex i component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome. / Van Rahden, Vanessa A.; Fernandez-Vizarra, Erika; Alawi, Malik; Brand, Kristina; Fellmann, Florence; Horn, Denise; Zeviani, Massimo; Kutsche, Kerstin.

In: American Journal of Human Genetics, Vol. 96, No. 4, 02.04.2015, p. 640-650.

Research output: Contribution to journalArticle

Van Rahden, Vanessa A. ; Fernandez-Vizarra, Erika ; Alawi, Malik ; Brand, Kristina ; Fellmann, Florence ; Horn, Denise ; Zeviani, Massimo ; Kutsche, Kerstin. / Mutations in NDUFB11, encoding a complex i component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome. In: American Journal of Human Genetics. 2015 ; Vol. 96, No. 4. pp. 640-650.
@article{096a20644ead4e228472061dde8f8736,
title = "Mutations in NDUFB11, encoding a complex i component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome",
abstract = "Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject's mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH:ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.",
author = "{Van Rahden}, {Vanessa A.} and Erika Fernandez-Vizarra and Malik Alawi and Kristina Brand and Florence Fellmann and Denise Horn and Massimo Zeviani and Kerstin Kutsche",
year = "2015",
month = "4",
day = "2",
doi = "10.1016/j.ajhg.2015.02.002",
language = "English",
volume = "96",
pages = "640--650",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Mutations in NDUFB11, encoding a complex i component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome

AU - Van Rahden, Vanessa A.

AU - Fernandez-Vizarra, Erika

AU - Alawi, Malik

AU - Brand, Kristina

AU - Fellmann, Florence

AU - Horn, Denise

AU - Zeviani, Massimo

AU - Kutsche, Kerstin

PY - 2015/4/2

Y1 - 2015/4/2

N2 - Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject's mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH:ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.

AB - Microphthalmia with linear skin defects (MLS) syndrome is an X-linked male-lethal disorder also known as MIDAS (microphthalmia, dermal aplasia, and sclerocornea). Additional clinical features include neurological and cardiac abnormalities. MLS syndrome is genetically heterogeneous given that heterozygous mutations in HCCS or COX7B have been identified in MLS-affected females. Both genes encode proteins involved in the structure and function of complexes III and IV, which form the terminal segment of the mitochondrial respiratory chain (MRC). However, not all individuals with MLS syndrome carry a mutation in either HCCS or COX7B. The majority of MLS-affected females have severe skewing of X chromosome inactivation, suggesting that mutations in HCCS, COX7B, and other as-yet-unidentified X-linked gene(s) cause selective loss of cells in which the mutated X chromosome is active. By applying whole-exome sequencing and filtering for X-chromosomal variants, we identified a de novo nonsense mutation in NDUFB11 (Xp11.23) in one female individual and a heterozygous 1-bp deletion in a second individual, her asymptomatic mother, and an affected aborted fetus of the subject's mother. NDUFB11 encodes one of 30 poorly characterized supernumerary subunits of NADH:ubiquinone oxidoreductase, known as complex I (cI), the first and largest enzyme of the MRC. By shRNA-mediated NDUFB11 knockdown in HeLa cells, we demonstrate that NDUFB11 is essential for cI assembly and activity as well as cell growth and survival. These results demonstrate that X-linked genetic defects leading to the complete inactivation of complex I, III, or IV underlie MLS syndrome. Our data reveal an unexpected role of cI dysfunction in a developmental phenotype, further underscoring the existence of a group of mitochondrial diseases associated with neurocutaneous manifestations.

UR - http://www.scopus.com/inward/record.url?scp=84926260422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926260422&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2015.02.002

DO - 10.1016/j.ajhg.2015.02.002

M3 - Article

C2 - 25772934

AN - SCOPUS:84926260422

VL - 96

SP - 640

EP - 650

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 4

ER -